Molecular Loop

Boston, United States Founded: 2018 • Age: 8 yrs
Targeted DNA sequencing technology is developed for clinical use.

About Molecular Loop

Molecular Loop is a company based in Boston (United States) founded in 2018 by Greg Porreca. Molecular Loop has raised $1.79 million across 1 funding round. The company has 12 employees. Molecular Loop has completed 1 acquisition, including Good Start Genetics. Molecular Loop offers products and services including LoopCap Technology, Custom Panels, and SARS-CoV-2 Research Panel. Molecular Loop operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.

  • Headquarter Boston, United States
  • Employees 12
  • Founders Greg Porreca
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website molecularloop.com
  • Social LinkedIn X
  • Legal Name Molecular Loop Biosciences, Inc.
Key Metrics
  • Total Equity Funding
    $1.79M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.79M (USD), Seed

    Jan 2022

  • Employee Count
    12
  • Investments & Acquisitions

Products & Services of Molecular Loop

Molecular Loop offers a comprehensive portfolio of products and services, including LoopCap Technology, Custom Panels, and SARS-CoV-2 Research Panel.

LoopCap Technology
Sequencing Tool

Enables single-tube workflow for target capture in next-generation sequencing.

Custom Panels
Genomic Assays

Allows flexible design of custom sequencing panels for research applications.

SARS-CoV-2 Research Panel
Disease-Specific Tool

Facilitates pathogen coverage for infectious disease genomic analysis.

Funding Insights of Molecular Loop

Molecular Loop has successfully raised a total of $1.79M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.79 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.79M
  • Total Rounds 1
  • Last Round Seed β€” $1.79M
  • First Round $1.79M

    (Jan 2022)

All 1 funding rounds of Molecular Loop with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2022$1.79MSeed––
–

People of Molecular Loop

1 people are tracked at Molecular Loop (1 in leadership); the tracked headcount is 12.

NameRoleGroup
Greg Porreca
Founder and CEOLeadership
Premium access

Complete people profiles for Molecular Loop

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Molecular Loop

Molecular Loop has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Good Start Genetics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Molecular diagnostics for inherited genetic disease screening are provided.
goodstartgenetics.comBoston, United States2008Oct 2018β€’β€’β€’β€’
Premium access

Complete acquisition details for Molecular Loop

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Molecular Loop

3 dated milestones of Molecular Loop across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Molecular Loop is founded.
  2. Acquisition Acquires Good Start Genetics.
  3. Funding First funding round of $1.8M.

Competitors of Molecular Loop

Molecular Loop operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nanoporetech.com2005Oxford, United Kingdom$1.26B705
Nanopore-based electronic systems for single-molecule analysis are developed.
pacb.com2004Menlo Park, United States$395M649
Instrument systems and software for single-molecule real-time sequencing are developed.
omniome.com2013San Diego, United States$160.23M164
Genome sequencing platform is provided for clinical diagnostics.
completegenomics.com2006San Jose, United States$124.99M70
DNA sequencing platform for human genome analysis is developed.
quantumdx.com2008Newcastle Upon Tyne, United Kingdom$57.26M98
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
bionano.com2002San Diego, United States$124.2M–
Provider of genome analysis solutions to researchers and clinicians
genapsys.com2010Redwood, United States$313.03M60
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
singulargenomics.com2016San Diego, United States–169
Next-generation gene sequencing and multi-omics technologies are provided.
raindancetech.com2004Billerica, United States$111.66M105
Developer of nucleic acid detection and quantification systems
Premium access

Detailed competitors of Molecular Loop

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Molecular Loop

The website of Molecular Loop (molecularloop.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 85.9% vs previous month

Latest news on Molecular Loop

Premium access

Complete news archive for Molecular Loop

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Molecular Loop

10 companies that operate in the same segment as Molecular Loop (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Molecular Loop

Molecular Loop was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Molecular Loop is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Greg Porreca is the current CEO of Molecular Loop. They have also founded this company.

Molecular Loop is a funded company, having raised a total of $1.79M across 1 funding round to date. The company's 1st funding round was a Seed of $1.79M, raised on Jan 2022.

Molecular Loop has 12 employees.

Founded in 2018 and based in Boston, United States, the company operates in the biotechnology sector. Ultra-high-throughput next-generation sequencing solutions are provided for clinical applications and large-scale research projects. Workflow simplification is achieved, along with reductions in cost and time, while throughput is increased and result quality is maintained. Targeted DNA sequencing technology forms the core of these operations.

Molecular Loop's top competitors include Nanopore, PacBio and QuantuMDx.

Molecular Loop offers LoopCap Technology, Custom Panels, and SARS-CoV-2 Research Panel.

Molecular Loop has made 1 acquisition, including Good Start Genetics.

Molecular Loop operates through Molecular Loop Biosciences, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available